Antipsychotic treatment of psychotic disorders in forensic psychiatry: Patients' perception of coercion and its predictors

被引:13
作者
Horvath, Juliane [1 ]
Steinert, Tilman [1 ]
Jaeger, Susanne [1 ]
机构
[1] Zentrum Psychiat Sudwurttemberg, Klin Psychiat & Psychotherapie Weissenau, Weingartshofer Str 2, D-88214 Ravensburg, Germany
关键词
Coercion; Schizophrenia; Forensic psychiatry; Drug attitude; Insight; Medication; INVOLUNTARY HOSPITALIZATION; MEDICATION; SCHIZOPHRENIA; CARE;
D O I
10.1016/j.ijlp.2018.02.004
中图分类号
D9 [法律]; DF [法律];
学科分类号
0301 ;
摘要
Background: Despite the major encroachment of coercive measures on the fundamental rights of affected forensic psychiatric patients, there is relatively few research done in this field. Considering the relevance of this subject for psychiatric care and the recent changes of the legal basis of coercive treatment in Germany, more studies are needed. The present study examines forensic psychiatric inpatients' perception of coercion regarding the prescribed antipsychotic medication and factors associated with the perception of coercion. Material and methods: Patients with schizophrenia, schizotypal and delusional disorders in two forensic psychiatric institutions in Southern Germany were interviewed about their experience of coercion related to antipsychotic medication. Due to a lack of appropriate psychometric scales, the perception of coercion regarding antipsychotic medication was assessed using an adapted version of the MacArthur Admission Experience Survey (aAES). The influence of sociodemographic and illness-related factors, of the attitude towards medication, insight into illness and symptom severity on the extent to which patients felt coerced to take the prescribed medication was analyzed. Two Visual Analog Scales, the Drug Attitude Inventory DAM 0, the Positive and Negative Syndrome Scale PANSS, the Fragebogen zur Krankheitseinsicht (Questionnaire about insight into illness) FKE-10 and the Coercion Experience Scale CES were used as psychometric scales. Results: 50% of all patients eligible for the study gave their written consent. 70% of all participants had experienced coercive measures between admission and time of data assessment. The DA1-10 and the aAES correlated moderately, a high level of insight into illness being correlated to less perceived coercion. The FKE-10 and the aAES correlated moderately as well, a high level of insight into illness being correlated to less perceived coercion. The severity of symptoms (PANSS score) and the level of perceived coercion (aAES score) correlated weakly, participants with more severe symptoms perceived more coercion than those with less marked symptoms. A linear regression model showed that to what extent patients felt coerced to take the prescribed antipsychotic medication was mainly influenced by their attitude towards medication and the degree of insight into illness, to a lesser extent by symptom severity (R2 = 0.565, p < 0,001). Sociodemographic factors were not related to the extent to which patients felt coerced to take the antipsychotic medication. Conclusions: Predictors of the experience of coercion related to the prescribed antipsychotic medication of forensic psychiatric inpatients with schizophrenia and related disorders are not so much sociodemographic or illness related factors as education or past medical history, but rather potentially influenceable variables such as insight into illness or attitude towards medication. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 28 条
  • [11] Coercive Measures in Forensic Settings: Findings from the Literature
    Hui, Ada
    Middleton, Hugh
    Voellm, Birgit
    [J]. INTERNATIONAL JOURNAL OF FORENSIC MENTAL HEALTH, 2013, 12 (01) : 53 - 67
  • [12] First report from the Swedish National Forensic Psychiatric Register (SNFPR)
    Innocenti, Alessio Degl'
    Hassing, Linda B.
    Lindqvist, Ann-Sophie
    Andersson, Hans
    Eriksson, Lars
    Hanson, Frances Hagelback
    Moller, Nina
    Nilsson, Thomas
    Hofvander, Bjorn
    Anckarsater, Henrik
    [J]. INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY, 2014, 37 (03) : 231 - 237
  • [13] Enhancement of outpatient treatment adherence Patients' perceptions of coercion, fairness and effectiveness
    Jaeger, Matthias
    Rossler, Wulf
    [J]. PSYCHIATRY RESEARCH, 2010, 180 (01) : 48 - 53
  • [14] Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion
    Jaeger, Susanne
    Pfiffner, Carmen
    Weiser, Prisca
    Laengle, Gerhard
    Croissant, Daniela
    Schepp, Wiltrud
    Kilian, Reinhold
    Becker, Thomas
    Eschweiler, Gerhard
    Steinert, Tilman
    [J]. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2013, 48 (11) : 1787 - 1796
  • [15] Coerced medication in psychiatric inpatient care: literature review
    Jarrett, Manuela
    Bowers, Len
    Simpson, Alan
    [J]. JOURNAL OF ADVANCED NURSING, 2008, 64 (06) : 538 - 548
  • [16] Involuntary medication in psychiatric inpatient treatment
    Kaltiala-Heino, R
    Välimäki, M
    Korkeila, J
    Tuohimäki, C
    Lehtinen, V
    [J]. EUROPEAN PSYCHIATRY, 2003, 18 (06) : 290 - 295
  • [17] THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) FOR SCHIZOPHRENIA
    KAY, SR
    FISZBEIN, A
    OPLER, LA
    [J]. SCHIZOPHRENIA BULLETIN, 1987, 13 (02) : 261 - 276
  • [18] Subjective experience of coercion in psychiatric care: a study comparing the attitudes of patients and healthy volunteers towards coercive methods and their justification
    Mielau, J.
    Altunbay, J.
    Gallinat, J.
    Heinz, A.
    Bermpohl, F.
    Lehmann, A.
    Montag, C.
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2016, 266 (04) : 337 - 347
  • [19] Use of the CONSORT statement and quality of reports of randomized trials - A comparative before-and-after evaluation
    Moher, D
    Jones, A
    Lepage, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (15): : 1992 - 1995
  • [20] DAI-10 is as good as DAI-30 in schizophrenia
    Nielsen, Rene Ernst
    Lindstrom, Eva
    Nielsen, Jimmi
    Levander, Sten
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (10) : 747 - 750